Evidence map›Paper›PMID 42193240›Full record

ArticleAntioxidants (Basel, Switzerland)2026

Regulation of Ferroptosis Sensitivity in Hepatocellular Carcinoma Cells by Lysosomal Ion Channels TPC2 and TRPML1.

Franz Geisslinger, Victoria Gell, Finja Witt, Dawid Jaślan, Christian Grimm, Andreas Koeberle, Karin Bartel

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Franz GeisslingerDepartment of Pharmacy, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
Victoria GellDepartment of Pharmacy, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
Finja WittMichael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020 Innsbruck, Austria.
Dawid JaślanWalther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.ORCID 0000-0002-0685-7633
Christian GrimmWalther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.ORCID 0000-0002-0177-5559
Andreas KoeberleMichael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-6269-5088
Karin BartelDepartment of Pharmacy, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.

Funding

Bundesministerium für Forschung, Technologie und Raumfahrt CNATM Project ID: 03ZU1201AAGerman Research Foundation BA 7238/2-1, SFB/TRR152 P04, SFB1328 A21, GRK2338 P08, DFG GR4315/6-1 and DFG GR4315/7-1
6 · The paper itself

Abstract

Ferroptosis is an iron-dependent, lipid peroxidation-driven form of regulated cell death that has emerged as a therapeutic vulnerability in hepatocellular carcinoma (HCC), yet the contribution of lysosomes to this process remains incompletely understood. In this study, we investigated whether lysosomal ion channels regulate ferroptosis sensitivity in HCC cells, focusing on the two-pore channel 2 (TPC2) and the transient receptor potential mucolipin 1 (TRPML1). Using pharmacological modulation, genetic knockout models, flow cytometry-based cell death and lipid peroxidation assays, lipidomics, calcium measurements, and molecular analyses across multiple HCC cell lines, we examined how these channels influence ferroptotic signaling. We show that NAADP-dependent TPC2 activity is required for efficient ferroptosis induction, whereas TPC2 loss renders HCC cells resistant to ferroptosis triggered by system Xc

Indexed as

ACSL4calcium signalingferroptosishepatocellular carcinomalipid peroxidationlysosomesoxidative stressredox biologyTPC2TRPML1

Identifiers

PMID42193240
PMCPMC13203517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.